Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status

PURPOSE: Phosphorylated ribosomal S6 kinase 1 (pS6K1) is a major downstream regulator of the mammalian target of rapamycin (mTOR) pathway. Recent studies have addressed the role of S6K1 in adipogenesis. pS6K1 may affect the outcome of estrogen depletion therapy in patients with hormone-sensitive bre...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jihye, Park, Chan Sub, Seong, Min-Ki, Seol, Hyesil, Kim, Jae-Sung, Park, In-Chul, Noh, Woo Chul, Kim, Hyun-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043945/
https://www.ncbi.nlm.nih.gov/pubmed/32140266
http://dx.doi.org/10.4048/jbc.2020.23.e5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043945/
https://www.ncbi.nlm.nih.gov/pubmed/32140266
http://dx.doi.org/10.4048/jbc.2020.23.e5

Ejemplares similares